Navigation Links
Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
Date:3/15/2011

any that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

Securities Law DisclosuresThe solicitation of proxies for the election of directors is made pursuant to a proxy statement filed with United States Securities and Exchange Commission. Cepheid shareholders and other investors are advised to read carefully the proxy statement relating to Cepheid's 2011 annual meeting of shareholders and any other relevant documents filed by Cepheid with the United States Securities and Exchange Commission before making any voting decision, because they contain important information.

Copies of the proxy statement and any other relevant documents are available to Cepheid shareholders at no expense to them.  In addition, those materials are available without charge from Cepheid Investor Relations at (408) 400-8329 or by email at investor.relations@cepheid.com, or the United States Securities and Exchange Commission through the Commission's website at www.sec.gov.  CONTACTS:For Media Inquiries:For Investor Inquiries:Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400-8377


SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Calif. , May 22, 2015 /PRNewswire/ ... the Company has commenced termination of its ... brodalumab with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... inhibitor, is in development for patients with ... spondyloarthritis.  The decision was based on events ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... approval of Zarxio (filgrastim-sndz) -- the first biosimilar ... -- points toward growth in the ... Information. The mainstream CMO industry is geared to ... infrastructure to produce major biopharmaceutical products. The healthcare ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... swiftly authorize a Special Enrollment Period to allow patients to ... if the patient believes that material misrepresentations led them to ... access, the National Community Pharmacists Association (NCPA) said ... year on January 1, local pharmacists have heard repeated complaints ...
... Jan. 19, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. ... based product line has experienced double digit sales growth ... line is expected to generate an estimated 50 million ...  The strength of the Company,s core product lines and ...
Cached Medicine Technology:Pharmacists Ask Medicare to Help Seniors Complaining About Inadequate Pharmacy Access in Medicare Prescription Drug Plans 2Pharmacists Ask Medicare to Help Seniors Complaining About Inadequate Pharmacy Access in Medicare Prescription Drug Plans 3China Health Resource Pharmaceutical Grade Gastrodia Product Line Expected to Contribute $8 Million in Revenue to 2011 Year End 2China Health Resource Pharmaceutical Grade Gastrodia Product Line Expected to Contribute $8 Million in Revenue to 2011 Year End 3
(Date:5/22/2015)... (PRWEB) May 22, 2015 Hands On ... June 17, 2015, the Annual One Day Sale ... 2007, Hands On HCMT offers drastically reduced certificates one day ... estheticians have enough sessions, through what used to be the ... wonderful for the community as well. This once a year ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the ... offering some tips to help promote safe travel. , According ... 383 traffic fatalities this Memorial Day weekend. Amica is sharing ... Safety Association: , , Always wear ... a seatbelt, whether they’re driving or riding along as a ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
(Date:5/22/2015)... A Phase 3 French study, ... of Clinical Oncology (ASCO)’s annual meeting at the ... those patients who received bevacizumab in addition to ... (Avastin® Genentech, Inc.) is an antibody that blocks ... routinely used to treat many other cancers, including ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President and ... by Consulting-Specifying Engineer (CSE) magazine as a young leader ... the May/June issue of the publication. , This award ... and younger who have, and continue to make significant ... other areas of their professional and personal endeavors. Candidates ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2
... HealthDay Reporter , THURSDAY, Dec. 16 (HealthDay ... approval of the drug Avastin to fight breast cancer, ... its potential for serious side effects. But the ... officials at a news conference, will not immediately affect ...
... , , , , , ... AUDIO: People with a known risk for Alzheimers disease ... Click here for more information. , , ... , , , , , ...
... , THURSDAY, Dec. 16 (HealthDay News) -- A new study ... overqualified workers can bring to their companies. "If anything, ... to stay longer and perform better than an applicant whose ... assistant professor of management at the University of South Carolina, ...
... from Italy determined that radiofrequency ablation (RFA) is a ... in cirrhotic patients. The high repeatability of RFA is ... liver. Results of this 10-year retrospective study are available ... a journal published by Wiley-Blackwell on behalf of the ...
... WASHINGTON The American College of Physicians (ACP) today made a ... available free for ordering and distribution. Consumer Guide to ... English and Spanish and organized in a way that clearly ... made and when the changes will take effect. It ...
... The World Health Organization set a target for the influenza ... elderly population and an increase to more than 75% by ... the old German states. In the current issue of ... 107[48]: 845󈞞) the working group around Annicka M. Reuss presents ...
Cached Medicine News:Health News:FDA Advises Against Avastin as Treatment for Breast Cancer 2Health News:FDA Advises Against Avastin as Treatment for Breast Cancer 3Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 2Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 3Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 4Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 5Health News:Overqualified Workers May Be Less Likely to Quit Jobs 2Health News:Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation 2
... sized High-Throughput Submarine Systems are designed ... from microtitre plates. Analyze high numbers ... oligos or PCR products simultaneously. The ... accuracy and speed with additional savings ...
... Dodeca cell runs up to 12 mini ... minutes. Handcast gels can be poured 12 ... 485 gradient former and Mini-PROTEAN 3 multi-casting ... reproducibility. Alternatively, Ready Gel precast gels offer ...
... Criterion Dodeca cell, a component of the Criterion ... to 12 Criterion gels in a single run. ... 8.7 cm) than the traditional mini gel. They ... give you the optimal combination of separation and ...
... runs up to 12 mini gels under ... gels can be poured 12 at a ... former and Mini-PROTEAN 3 multi-casting chamber, eliminating ... Ready Gel precast gels offer the convenience ...
Medicine Products: